{"DataElement":{"publicId":"3637897","version":"1","preferredName":"Immunodeficiency Molecular Abnormality Type","preferredDefinition":"A description of the immunodeficiency molecular abnormality.","longName":"3637841v1.0:3637865v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3637841","version":"1","preferredName":"Immunodeficiency Molecular Abnormality","preferredDefinition":"A disorder in which the immune system is unable to mount an adequate immune response._A molecular or cytogenic abnormality which occurs in either human disease states or disease models.","longName":"3637838v1.0:3637839v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3637838","version":"1","preferredName":"Immunodeficiency","preferredDefinition":"A disorder in which the immune system is unable to mount an adequate immune response.","longName":"C39725","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency","conceptCode":"C39725","definition":"A disorder in which the immune system is unable to mount an adequate immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01DACC5-371A-AA58-E040-BB89AD432A3E","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3637839","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01DACC5-3727-AA58-E040-BB89AD432A3E","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01DACC5-3738-AA58-E040-BB89AD432A3E","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeDescription":". 2021-4-26 ak Ok to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3637865","version":"1","preferredName":"Immunodeficiency Molecular Abnormality Type","preferredDefinition":"A disorder in which the immune system is unable to mount an adequate immune response._A molecular or cytogenic abnormality which occurs in either human disease states or disease models._Something distinguishable as an identifiable class based on common qualities.","longName":"3637865v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4AFD-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4B07-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Orai 1 deficiency","valueDescription":"Calcium Released-Activated Calcium Channel Protein 1 Deficiency","ValueMeaning":{"publicId":"3637866","version":"1","preferredName":"Calcium Released-Activated Calcium Channel Protein 1 Deficiency","longName":"3637866","preferredDefinition":"Calcium release-activated calcium channel protein 1 (301 aa, ~33 kDa) is encoded by the human ORA1 gene.  This protein plays a role in both the regulation of celluar calcium concentration and the transcription of pathogen responsive genes.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calcium Release-Activated Calcium Channel Protein 1","conceptCode":"C88519","definition":"Calcium release-activated calcium channel protein 1 (301 aa, ~33 kDa) is encoded by the human ORAI1 gene. This protein plays a role in both the regulation of cellular calcium concentration and the transcription of pathogen responsive genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4B14-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4B2D-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Cartilage-hair hypoplasia / metaphyseal dysplasia, McKusick type","valueDescription":"Cartilage Hair Hypoplasia","ValueMeaning":{"publicId":"3322411","version":"1","preferredName":"Cartilage Hair Hypoplasia","longName":"3322411","preferredDefinition":"A rare autosomal recessive inherited disorder caused by mutation in the gene for RNAase RMRP. It is characterized by short-limb dwarfism, presence of fine sparse hair, and T-and B-cell immunodeficiency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cartilage Hair Hypoplasia","conceptCode":"C61245","definition":"A rare autosomal recessive inherited disorder caused by mutation in the gene for RNAase RMRP. It is characterized by short-limb dwarfism, presence of fine sparse hair, and T-and B-cell immunodeficiency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BDAA-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4B41-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Bare lymphocyte syndrome deficiency","valueDescription":"Bare Lymphocyte Syndrome Deficiency","ValueMeaning":{"publicId":"3637867","version":"1","preferredName":"Bare Lymphocyte Syndrome Deficiency","longName":"3637867","preferredDefinition":"A hereditary immunodeficiency disorder caused by the absence of major histocompatibility complex class II expression. Signs and symptoms include upper and lower respiratory tract bacterial infections, malabsorption, diarrhea, and mucocutaneous candidiasis.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bare Lymphocyte Syndrome","conceptCode":"C3895","definition":"A hereditary immunodeficiency disorder caused by the lack of expression of major histocompatibility complex (MHC) proteins. Signs include upper and lower respiratory tract bacterial infections, malabsorption, diarrhea, and mucocutaneous candidiasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4B4E-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4B67-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Omenn syndrome","valueDescription":"Omenn Syndrome","ValueMeaning":{"publicId":"3323722","version":"1","preferredName":"Omenn Syndrome","longName":"3323722","preferredDefinition":"An autosomal recessive combined immunodeficiency syndrome caused by mutations in the RAG-1 and RAG-2 genes. It is characterized by the presence of alopecia, erythroderma, desquamation, lymphadenopathy, and chronic diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Omenn Syndrome","conceptCode":"C61240","definition":"An autosomal recessive combined immunodeficiency syndrome caused by mutations in the RAG-1 and RAG-2 genes. It is characterized by the presence of alopecia, erythroderma, desquamation, lymphadenopathy, and chronic diarrhea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B381BEF5-8345-6627-E040-BB89AD4359F7","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"ONEDATA","dateModified":"2011-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4B7B-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Adenylate kinase 2 deficiency","valueDescription":"Reticular Dysgenesis","ValueMeaning":{"publicId":"3326327","version":"1","preferredName":"Reticular Dysgenesis","longName":"3326327","preferredDefinition":"A rare severe combined immunodeficiency disorder characterized by congenital agranulocytosis, lymphoid tissue and thymic tissue hypoplasia, and lymphopenia. Both cellular and humoral immunities are absent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reticular Dysgenesis","conceptCode":"C27070","definition":"A rare severe combined immunodeficiency disorder characterized by congenital agranulocytosis, lymphoid tissue and thymic tissue hypoplasia, and lymphopenia. Both cellular and humoral immunities are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3862B52-B5B2-375A-E040-BB89AD436460","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"ONEDATA","dateModified":"2011-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4B8F-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"DNA-protein kinase catalytic subunit deficiency","valueDescription":"DNA-Dependent Protein Kinase Catalytic Subunit Deficiency","ValueMeaning":{"publicId":"3637869","version":"1","preferredName":"DNA-Dependent Protein Kinase Catalytic Subunit Deficiency","longName":"3637869","preferredDefinition":"DNA-dependent protein kinase catalytic subunit (4128 aa, ~469 kDa) is encoded by the human PRKDC gene. This protein is involved in both DNA damage response and protein phosphorylation.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA-Dependent Protein Kinase Catalytic Subunit","conceptCode":"C21483","definition":"DNA-dependent protein kinase catalytic subunit (4128 aa, ~469 kDa) is encoded by the human PRKDC gene. This protein is involved in both DNA damage response and protein phosphorylation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4B9D-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4BB6-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"DNA ligase 4 deficiency","valueDescription":"DNA Ligase 4 Deficiency","ValueMeaning":{"publicId":"3637871","version":"1","preferredName":"DNA Ligase 4 Deficiency","longName":"3637871","preferredDefinition":"DNA ligase 4 (911 aa, ~104 kDa) is encoded by the human LIG4 gene. This protein plays a role in non-homologous end joining during both DNA repair and V(D)J recombination.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA Ligase 4","conceptCode":"C21463","definition":"DNA ligase 4 (911 aa, ~104 kDa) is encoded by the human LIG4 gene. This protein plays a role in non-homologous end joining during both DNA repair and V(D)J recombination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4BC4-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4BDD-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Cernunnos-XLF / NHEJ1 deficiency","valueDescription":"Nonhomologous End-Joining Factor 1 Deficiency","ValueMeaning":{"publicId":"3637873","version":"1","preferredName":"Nonhomologous End-Joining Factor 1 Deficiency","longName":"3637873","preferredDefinition":"Non-homologous end-joining factor 1 (299 aa, ~33 kDa) is encoded by the human NHEJ1 gene. This protein is involved in both the repair of double-strand breaks in DNA and nonhomologous end-joining.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonhomologous End-Joining Factor 1","conceptCode":"C88515","definition":"Non-homologous end-joining factor 1 (299 aa, ~33 kDa) is encoded by the human NHEJ1 gene. This protein is involved in both the repair of double-strand breaks in DNA and nonhomologous end-joining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4BEB-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4C04-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Purine nucleoside phosphorylase deficiency","valueDescription":"Purine Nucleoside Phosphorylase Deficiency","ValueMeaning":{"publicId":"3637875","version":"1","preferredName":"Purine Nucleoside Phosphorylase Deficiency","longName":"3637875","preferredDefinition":"The enzyme purine nucleoside phosphorylase belongs to the PNP/MTAP phosphorylase family and together with adenosine deaminase (ADA) serves a key role in purine catabolism, referred to as the salvage pathway. Defects in NP are the cause of nucleoside phosphorylase deficiency (NP deficiency). It leads to a severe T-cell immunodeficiency with neurologic disorder in children.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Purine Nucleoside Phosphorylase","conceptCode":"C43241","definition":"Purine nucleoside phosphorylase (289 aa, ~32 kDa) is encoded by the human PNP gene. This protein plays a role in purine metabolism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4C12-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4C2B-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"CD45 deficiency","valueDescription":"Receptor-Type Tyrosine-Protein Phosphatase C Deficiency","ValueMeaning":{"publicId":"3637877","version":"1","preferredName":"Receptor-Type Tyrosine-Protein Phosphatase C Deficiency","longName":"3637877","preferredDefinition":"Receptor-type tyrosine-protein phosphatase C (1304 aa, ~147 kDa) is encoded by the human PTPRC gene. This protein plays a role in protein dephosphorylation.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Receptor-Type Tyrosine-Protein Phosphatase C","conceptCode":"C17282","definition":"Receptor-type tyrosine-protein phosphatase C (1304 aa, ~147 kDa) is encoded by the human PTPRC gene. This protein plays a role in protein dephosphorylation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4C39-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4C52-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"CD25 deficiency","valueDescription":"Interleukin-2 Receptor Alpha Chain Deficiency","ValueMeaning":{"publicId":"3637878","version":"1","preferredName":"Interleukin-2 Receptor Alpha Chain Deficiency","longName":"3637878","preferredDefinition":"Interleukin-2 receptor alpha chain (272 aa, 31 kD) is a cell fate protein that is encoded by the human IL2RA gene and has roles in immune response, cell proliferation, apoptosis and signal transduction.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interleukin-2 Receptor Subunit Alpha","conceptCode":"C17073","definition":"Interleukin-2 receptor subunit alpha (272 aa, ~31 kDa) is encoded by the human IL2RA gene. This protein plays a role in interleukin-2-dependent signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4C5F-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4C78-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Zeta-chain associated protein kinase kDa deficiency","valueDescription":"Zeta-Chain Associated Protein Kinase Deficiency","ValueMeaning":{"publicId":"3637880","version":"1","preferredName":"Zeta-Chain Associated Protein Kinase Deficiency","longName":"3637880","preferredDefinition":"A protein tyrosine kinase in the syk family of kinases, with signaling functions in the T-cell receptor (TCR) signal transduction pathway.  Associates with the zeta and CD3 chains of the receptor.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tyrosine-Protein Kinase ZAP-70","conceptCode":"C17596","definition":"Tyrosine-protein kinase ZAP-70 (619 aa, ~70 kDa) is encoded by the human ZAP70 gene. This protein plays a role in both tyrosine phosphorylation and adaptive immunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4C86-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4C9F-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"CD3 zeta-chain deficiency","valueDescription":"T-Cell Receptor T3 Zeta Chain Deficiency","ValueMeaning":{"publicId":"3637881","version":"1","preferredName":"T-Cell Receptor T3 Zeta Chain Deficiency","longName":"3637881","preferredDefinition":"Encoded as alternative isoforms by T-cell specific human CD3Z Gene (CD3Z/FCER1G Family), conserved nonglycosylated T-Cell Receptor-T3 Zeta Chain is a cell surface type I membrane protein containing 3 ITAM domains and a subunit of the CD3 complex (CD3D, CD3E, CD3G, CD3Zeta/Eta) noncovalently associated with disulfide bound alpha/beta and gamma/delta TCR. CD3-zeta forms disulfide-linked homodimers or heterodimers with CD3-eta, couples antigen recognition to signal transduction pathways, and may be associated with the cytoskeleton. CD3Z interacts with SLA, SLA2, and DOCK2. Enhancing T-cell antigen sensitivity, accessory protein CD4 binds to MHC II molecules and to LCK, which phosphorylates CD3Z. CD3 plays a role in the transition of immature thymocytes to mature CD4+ or CD8+ T cells. Following TCR engagement, CD3 activity leads to T-cell activation. (NCI): In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Zeta Chain","conceptCode":"C38903","definition":"T-cell surface glycoprotein CD3 zeta chain (164 aa, ~18 kDa) is encoded by the human CD247 gene. This protein is involved in T-cell intracellular signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4CAC-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4CC5-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"CD3 epsilon deficiency","valueDescription":"T-Cell Surface Glycoprotein CD3 Epsilon Chain Deficiency","ValueMeaning":{"publicId":"3637883","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Epsilon Chain Deficiency","longName":"3637883","preferredDefinition":"T-cell surface glycoprotein CD3 epsilon chain (207 aa, ~23 kDa) is encoded by the human CD3E gene. This protein plays a role in immune receptor signaling.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Epsilon Chain","conceptCode":"C25792","definition":"T-cell surface glycoprotein CD3 epsilon chain (207 aa, ~23 kDa) is encoded by the human CD3E gene. This protein plays a role in immune receptor signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4CD3-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4CEC-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"CD3 delta deficiency","valueDescription":"T-Cell Surface Glycoprotein CD3 Delta Chain Deficiency","ValueMeaning":{"publicId":"3637885","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Delta Chain Deficiency","longName":"3637885","preferredDefinition":"T-cell surface glycoprotein CD3 delta chain (171 aa, ~19 kDa) is encoded by the human CD3D gene. This protein is involved in T-cell-mediated immunity.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Delta Chain","conceptCode":"C38899","definition":"T-cell surface glycoprotein CD3 delta chain (171 aa, ~19 kDa) is encoded by the human CD3D gene. This protein is involved in T-cell-mediated immunity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4CFA-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4D13-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"CD3 gamma deficiency","valueDescription":"T-Cell Surface Glycoprotein CD3 Gamma Chain Deficiency","ValueMeaning":{"publicId":"3637887","version":"1","preferredName":"T-Cell Surface Glycoprotein CD3 Gamma Chain Deficiency","longName":"3637887","preferredDefinition":"T-cell surface glycoprotein CD3 gamma chain (182 aa, ~20 kDa) is encoded by the human CD3G gene. This protein plays a role in T-cell receptor-mediated signaling.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T-Cell Surface Glycoprotein CD3 Gamma Chain","conceptCode":"C38901","definition":"T-cell surface glycoprotein CD3 gamma chain (182 aa, ~20 kDa) is encoded by the human CD3G gene. This protein plays a role in T-cell receptor-mediated signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4D21-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4D3A-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"IL-7R alpha deficiency","valueDescription":"Interleukin-7 Receptor Subunit Alpha Deficiency","ValueMeaning":{"publicId":"3637890","version":"1","preferredName":"Interleukin-7 Receptor Subunit Alpha Deficiency","longName":"3637890","preferredDefinition":"Interleukin-7 receptor subunit alpha (459 aa, ~52 kDa) is encoded by the human IL7R gene. This protein is involved in both interleukin binding and signal transduction.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interleukin-7 Receptor Subunit Alpha","conceptCode":"C26278","definition":"Interleukin-7 receptor subunit alpha (459 aa, ~52 kDa) is encoded by the human IL7R gene. This protein is involved in both interleukin binding and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4D55-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4D6E-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Recombination-activating gene 2 deficiency","valueDescription":"V(D)J Recombination-Activating Protein 2 Deficiency","ValueMeaning":{"publicId":"3637892","version":"1","preferredName":"V(D)J Recombination-Activating Protein 2 Deficiency","longName":"3637892","preferredDefinition":"V(D)J recombination-activating protein 2 (527 aa, ~59 kDa) is encoded by the human RAG2 gene. This protein plays a role in the mediation of V-D-J recombination.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"V(D)J Recombination-Activating Protein 2","conceptCode":"C80073","definition":"V(D)J recombination-activating protein 2 (527 aa, ~59 kDa) is encoded by the human RAG2 gene. This protein plays a role in the mediation of V-D-J recombination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4D7C-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4D95-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Recombination-activating gene 1 deficiency","valueDescription":"V(D)J Recombination-Activating Protein 1 Deficiency","ValueMeaning":{"publicId":"3637894","version":"1","preferredName":"V(D)J Recombination-Activating Protein 1 Deficiency","longName":"3637894","preferredDefinition":"V(D)J recombination-activating protein 1 (1043 aa, ~119 kDa) is encoded by the human RAG1 gene. This protein is involved in the regulation of V-D-J recombination.: In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"V(D)J Recombination-Activating Protein 1","conceptCode":"C80072","definition":"V(D)J recombination-activating protein 1 (1043 aa, ~119 kDa) is encoded by the human RAG1 gene. This protein is involved in the regulation of V-D-J recombination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4DA3-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4DBC-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Janus kinase 3 deficiency","valueDescription":"Janus Kinase 3 Deficiency","ValueMeaning":{"publicId":"3637895","version":"1","preferredName":"Janus Kinase 3 Deficiency","longName":"3637895","preferredDefinition":"This protein is a member of janus family. JAK3 functions in signal transduction and interacts with members of the STAT (signal transduction and activators of transcription) family. JAK3 is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations that abrogate janus kinase 3 function cause an autosomal SCID (severe combined immunodeficiency disease). (from LocusLink): In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tyrosine-Protein Kinase JAK3","conceptCode":"C28492","definition":"Tyrosine-protein kinase JAK3 (1124 aa, ~125 kDa) is encoded by the human JAK3 gene. This protein is involved in T-cell development, immunity, signaling and tyrosine phosphorylation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4DC9-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4DE2-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Adenosine deaminase deficiency","valueDescription":"Adenosine Deaminase Deficiency","ValueMeaning":{"publicId":"2593377","version":"1","preferredName":"Adenosine Deaminase Deficiency","longName":"2593377","preferredDefinition":"An autosomal recessive deficiency of the purine salvage enzyme adenosine deaminase which results in Severe Combined Immunodeficiency Disease (SCID).  The most common form of SCID, accounting for about 50% of autosomal recessive cases.  The first disease for which gene therapy was applied.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosine Deaminase Deficiency","conceptCode":"C3962","definition":"An autosomal recessive deficiency of the purine salvage enzyme adenosine deaminase which results in Severe Combined Immunodeficiency Disease (SCID).  The most common form of SCID, accounting for about 50% of autosomal recessive cases.  The first disease for which gene therapy was applied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2883B38F-10CD-4337-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4DF6-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"},{"value":"Common gamma chain deficiency","valueDescription":"Interleukin 2 Receptor Gamma Deficiency","ValueMeaning":{"publicId":"3637896","version":"1","preferredName":"Interleukin 2 Receptor Gamma Deficiency","longName":"3637896","preferredDefinition":"The interleukin 2 (IL2) receptor gamma chain (IL2RG) is an important signalling component of many interleukin receptors (e.g., IL2,IL4,IL7,IL9, and IL15) and is thus referred to as the common gamma chain. It is necessary for normal growth and differentiation of T cells, B cells, natural killer cells, glioma cells, and cells of the monocyte lineage.  Mutations in this X-chromosome-linked gene cause X-linked severe combined immunodeficiency (XSCID). (from LocusLink and OMIM): In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytokine Receptor Common Subunit Gamma","conceptCode":"C26266","definition":"Cytokine receptor common subunit gamma (369 aa, ~42 kDa) is encoded by the human IL2RG gene. This protein plays a role in both immune responses and interleukin signaling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deficiency","conceptCode":"C94372","definition":"In medicine, a shortage of a substance (such as a vitamin or mineral) needed by the body.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4E03-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D01F33BD-4E1C-FD68-E040-BB89AD4365B2","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3637864","version":"1","preferredName":"Immunodeficiency Molecular Abnormality Type","preferredDefinition":"A disorder in which the immune system is unable to mount an adequate immune response.:Abnormalities that occur in human cells and tissues and models of human cancer.:Something distinguishable as an identifiable class based on common qualities.","longName":"C39725:C3910:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency","conceptCode":"C39725","definition":"A disorder in which the immune system is unable to mount an adequate immune response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Molecular Abnormality","conceptCode":"C3910","definition":"A molecular or cytogenetic abnormality which occurs in either human disease states or disease models.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4AD6-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"ONEDATA","dateModified":"2012-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F33BD-4AE7-FD68-E040-BB89AD4365B2","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeDescription":". 2021-4-26 ak Ok to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3638517","version":"1","longName":"2031r2: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[{"name":"id_diag_id_molec_abnorm","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the immunodeficiency","type":"Preferred Question Text","description":"What was the immunodeficiency molecular abnormality?","url":null,"context":"NHLBI"},{"name":"What is the immune deficiency molecular abnormality?","type":"Alternate Question Text","description":"What is the immune deficiency molecular abnormality?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D01F3059-13BA-5161-E040-BB89AD4370C0","latestVersionIndicator":"Yes","beginDate":"2012-12-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2012-12-05","modifiedBy":"KUMMEROA","dateModified":"2021-04-26","changeDescription":". 2021-4-26 ak Ok to release per WZ. Added CSI for 2031r2. AK 12/6/12 2021-3-8 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}